Liminal Biosciences Inc

NASDAQ:LMNL   3:59:50 PM EDT
2.74
+0.13 (+4.98%)
Earnings Announcements

Liminal Biosciences Reports Q2 Net Loss Of $32.1 Million

Published: 08/16/2021 21:30 GMT
Liminal Biosciences Inc (LMNL) - Liminal Biosciences Reports Second Quarter 2021 Financial Results.
Liminal Biosciences Inc - Net Loss Was $32.1 Million for Q2 of 2021 Compared to $27.8 Million for Q2 of 2020.
Revenue is expected to be $0.11 Million
Adjusted EPS is expected to be -$0.27

Next Quarter Revenue Guidance is expected to be $27.99 Million
Next Quarter EPS Guidance is expected to be $0.87

More details on our Analysts Page.